Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Health Network, Toronto
Age
18–85
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Histologically confirmed prostate cancer
Currently receiving LHRH-agonist therapy for greater than 6 months
Measurable fatigue, defined as a score of ≥ 2 on the Bruera global fatigue severity scale
Able to swallow Red Bull™ Sugar-Free Drink
Life expectancy of at least 1 year
Able to read and write in English
Willing to limit consumption of alcohol to one drink per day
You may not be if
Current malignancy or received treatment for a previous malignancy within the last 3 years other than prostate cancer (exceptions are superficial bladder cancer or non-melanoma skin cancer)
Myocardial infarction within past 6 months
Any unstable serious co-existing medical condition(s) including but not limited to unstable or poorly controlled coronary artery disease, chronic atrial fibrillation, uncontrolled hypertension, uncontrolled diabetes, severe bleeding diseases or immune disorders
Evidence of drug or alcohol abuse
Known hypersensitivity to caffeine
Known history of liver and kidney insufficiencies
Known contraindications to Red Bull™ use
Clareo Health | Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy
